ALFA Finder
00:12 IST
NSE
Results Update
Sai Life Science Results Update
Sai Life Sciences posted Q2 FY27 revenue growth of 23% YoY, with H1 PAT up 19% to ₹172 Cr. The company incurred ₹621 Cr capex in H1.
Sai Life Science Ltd
- Share price
- ₹1,918.60
- Market cap
- ₹40,786 Cr
- Revenue (annual)
- ₹2,192 Cr
- Net profit (annual)
- ₹348.9 Cr
- P/E (TTM)
- 108.4×Sector 43.8×
- Promoter holding
- 34.50%-0.03% QoQ
- FII holding
- 19.91%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Employee Stock Options 11Other Announcement 5Earnings Call 5Financial Results 4Results Update 3Board Meeting Date 2Annual General Meeting 2Management Change 1Legal & Regulatory 1Business Update 1Board Meeting Outcome 1Annual Report 1
Time
3 announcements with these filters
23:16 IST
BSE
Results Update
Sai Life Science Results Update
Sai Life Sciences reported Q1 FY27 revenue of ₹554 crore and PAT of ₹73 crore. It also operationalized a new 100,000 sq. ft. R&D facility.
23:26 IST
BSE
Results Update
Sai Life Science Results Update
Sai Life Sciences reported FY26 revenue of ₹2,192 Crore, representing 29% growth. Net profit doubled to ₹355 Crore, driven by deep engagement with large pharma customers.